Industries
OMICS4's bookable platforms (extraction, QC, NGS & molecular biology, proteomics and exosome services) already run across four industry verticals, from immuno-oncology to drug discovery.
Multi-omics profiling of the tumor microenvironment for actionable biomarkers.
Skin biology, transcriptomics and microbiome profiling for dermo-cosmetic innovation.
Host-pathogen interactions and microbial ecology for infectious disease research.
Translational biomarker workflows to accelerate discovery programs.
Not sure which platform fits?